Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 7
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean coira a[au] (41 results)?
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis.
Ismaila AS, Haeussler K, Czira A, Youn JH, Malmenäs M, Risebrough NA, Agarwal J, Nassim M, Sharma R, Compton C, Vogelmeier CF, Han MK, Halpin DMG. Ismaila AS, et al. Among authors: czira a. Adv Ther. 2022 Sep;39(9):3957-3978. doi: 10.1007/s12325-022-02231-0. Epub 2022 Jul 17. Adv Ther. 2022. PMID: 35849317 Free PMC article. Review.
Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis.
Ismaila AS, Haeussler K, Czira A, Tongbram V, Malmenäs M, Agarwal J, Nassim M, Živković-Gojović M, Shen Y, Dong X, Duarte M, Compton C, Vogelmeier CF, Halpin DMG. Ismaila AS, et al. Among authors: czira a. Adv Ther. 2022 Nov;39(11):4961-5010. doi: 10.1007/s12325-022-02234-x. Epub 2022 Jul 20. Adv Ther. 2022. PMID: 35857184 Free PMC article.
Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review.
Czira A, Purushotham S, Iheanacho I, Rothnie KJ, Compton C, Ismaila AS. Czira A, et al. Int J Chron Obstruct Pulmon Dis. 2023 Apr 29;18:719-731. doi: 10.2147/COPD.S394325. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37151760 Free PMC article. Review.
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England.
Czira A, Requena G, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS. Czira A, et al. Int J Chron Obstruct Pulmon Dis. 2023 Apr 19;18:643-659. doi: 10.2147/COPD.S405498. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37155496 Free PMC article.
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
Ismaila AS, Rothnie KJ, Wood RP, Banks VL, Camidge LJ, Czira A, Compton C, Sharma R, Millard SN, Massey O, Halpin DMG. Ismaila AS, et al. Among authors: czira a. Respir Res. 2023 Sep 25;24(1):229. doi: 10.1186/s12931-023-02523-1. Respir Res. 2023. PMID: 37749551 Free PMC article.
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England.
Requena G, Banks V, Czira A, Wood R, Tritton T, Wild R, Compton C, Ismaila AS. Requena G, et al. Among authors: czira a. Int J Chron Obstruct Pulmon Dis. 2023 Mar 5;18:231-245. doi: 10.2147/COPD.S389281. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 36908830 Free PMC article.
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study.
Czira A, Akiyama S, Ishii T, Wood RP, Camidge LJ, Wallis H, Jennison T, Wild RAC, Yarita M, Hashimoto K, Rothnie KJ, Ismaila AS. Czira A, et al. Int J Chron Obstruct Pulmon Dis. 2023 Dec 8;18:2933-2953. doi: 10.2147/COPD.S419119. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 38089540 Free PMC article.
Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting.
Halpin DMG, Rothnie KJ, Banks V, Czira A, Compton C, Wood R, Tritton T, Massey O, Wild R, Snowise N, Nikitin K, Sharma R, Ismaila AS, Vogelmeier CF. Halpin DMG, et al. Among authors: czira a. Int J Chron Obstruct Pulmon Dis. 2022 Sep 24;17:2417-2429. doi: 10.2147/COPD.S370540. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36185170 Free PMC article.
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England.
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo C, Yeap J, Wild R, Compton C, Rothnie KJ, Herth FJF, Quint JK, Ismaila AS. Requena G, et al. Among authors: czira a. Int J Chron Obstruct Pulmon Dis. 2023 Sep 15;18:2039-2054. doi: 10.2147/COPD.S408688. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37731774 Free PMC article.
16 results